Abstract
Heart failure (HF) remains a major global health burden, with rising prevalence due to aging populations and improved survival from acute cardiac events. By 2025, advances in diagnostics, pharmacotherapy, and perioperative management have significantly reshaped outcomes for patients with heart failure undergoing surgical procedures. This article provides an updated overview of heart failure classification, evolving perioperative risk assessment strategies, and contemporary management principles relevant to surgical care.
Introduction
Heart failure is no longer considered a single disease entity but a complex clinical syndrome with diverse etiologies and phenotypes. Surgical intervention in patients with HF presents unique challenges due to compromised cardiac reserve, comorbidities, and altered physiological responses to anesthesia and stress. Recent guidelines emphasize individualized perioperative planning rather than blanket risk avoidance.
Evolving Classification of Heart Failure
Current classification systems recognize heart failure with reduced ejection fraction (HFrEF), mildly reduced ejection fraction (HFmrEF), and preserved ejection fraction (HFpEF). This stratification allows for more tailored perioperative decision-making and therapy optimization.
Perioperative Risk Assessment
Risk stratification in 2025 increasingly relies on:
- Functional capacity assessment
- Biomarkers such as natriuretic peptides
- Advanced imaging for myocardial reserve
- Multidisciplinary preoperative evaluation
These tools help identify patients who may benefit from optimization prior to elective surgery.
Perioperative Management Strategies
Key considerations include:
- Continuation of guideline-directed medical therapy where feasible
- Careful fluid management to avoid volume overload
- Hemodynamic monitoring in high-risk cases
- Early postoperative mobilization and monitoring
Conclusion
The perioperative management of heart failure patients has evolved from risk avoidance to risk mitigation. With appropriate assessment and multidisciplinary care, surgical outcomes in heart failure patients continue to improve in 2025.
